These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10194546)

  • 1. Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction.
    Matsumoto SS; Haughey HM; Schmehl DM; Venables DA; Ireland CM; Holden JA; Barrows LR
    Anticancer Drugs; 1999 Jan; 10(1):39-45. PubMed ID: 10194546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogs of the marine alkaloid makaluvamines: synthesis, topoisomerase II inhibition, and anticancer activity.
    Shinkre BA; Raisch KP; Fan L; Velu SE
    Bioorg Med Chem Lett; 2007 May; 17(10):2890-3. PubMed ID: 17368022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors.
    Barrows LR; Radisky DC; Copp BR; Swaffar DS; Kramer RA; Warters RL; Ireland CM
    Anticancer Drug Des; 1993 Oct; 8(5):333-47. PubMed ID: 8251041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Makaluvamine N: a new pyrroloiminoquinone from Zyzzya fuliginosa.
    Venables DA; Concepción GP; Matsumoto SS; Barrows LR; Ireland CM
    J Nat Prod; 1997 Apr; 60(4):408-10. PubMed ID: 9134749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
    Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
    Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of XR5944, a novel and potent topoisomerase poison.
    Stewart AJ; Mistry P; Dangerfield W; Bootle D; Baker M; Kofler B; Okiji S; Baguley BC; Denny WA; Charlton PA
    Anticancer Drugs; 2001 Apr; 12(4):359-67. PubMed ID: 11335793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage.
    Robinson MJ; Martin BA; Gootz TD; McGuirk PR; Moynihan M; Sutcliffe JA; Osheroff N
    J Biol Chem; 1991 Aug; 266(22):14585-92. PubMed ID: 1650363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
    Thielmann HW; Popanda O; Gersbach H; Gilberg F
    Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine.
    Marshall KM; Matsumoto SS; Holden JA; Concepción GP; Tasdemir D; Ireland CM; Barrows LR
    Biochem Pharmacol; 2003 Aug; 66(3):447-58. PubMed ID: 12907244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
    Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
    Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes.
    Osheroff N; Corbett AH; Elsea SH; Westergaard M
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S19-25. PubMed ID: 8070023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.
    Yamashita Y; Ashizawa T; Morimoto M; Hosomi J; Nakano H
    Cancer Res; 1992 May; 52(10):2818-22. PubMed ID: 1316228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.